Literature DB >> 352467

Kindling as a model for alcohol withdrawal syndromes.

J C Ballenger, R M Post.   

Abstract

Periodic brain stimulation, particularly in the limbic system, at stimulus intensities initially too low to produce any behavioural or EEG effects, progressively produces EEG changes, motor automatisms, and eventually convulsions, an effect called kindling. Data are presented and reviewed that suggest that the severity of alcohol withdrawal symptoms progressively increases over years of alcohol abuse in a stepwise fashion similar to the kindling process. The model is presented that the limbic system hyperirritability which accompanies each alcohol withdrawal serves over time to kindle increasingly widespread subcortical structures. These long-term changes in neuronal excitability might relate to the progression of alcohol withdrawal symptoms from tremor to seizures and delirium tremens, as well as the alcoholic personality changes between episodes of withdrawal.

Entities:  

Mesh:

Year:  1978        PMID: 352467     DOI: 10.1192/bjp.133.1.1

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  98 in total

1.  Genotype Differences in Sensitivity to the Anticonvulsant Effect of the Synthetic Neurosteroid Ganaxolone during Chronic Ethanol Withdrawal.

Authors:  Michelle A Nipper; Jeremiah P Jensen; Melinda L Helms; Matthew M Ford; John C Crabbe; David J Rossi; Deborah A Finn
Journal:  Neuroscience       Date:  2018-12-02       Impact factor: 3.590

2.  Persistent escalation of alcohol drinking in C57BL/6J mice with intermittent access to 20% ethanol.

Authors:  Lara S Hwa; Adam Chu; Sally A Levinson; Tala M Kayyali; Joseph F DeBold; Klaus A Miczek
Journal:  Alcohol Clin Exp Res       Date:  2011-06-01       Impact factor: 3.455

3.  Stress sensitization of ethanol withdrawal-induced reduction in social interaction: inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A-receptor agonist.

Authors:  George R Breese; Darin J Knapp; David H Overstreet
Journal:  Neuropsychopharmacology       Date:  2004-03       Impact factor: 7.853

Review 4.  Glucocorticoid and polyamine interactions in the plasticity of glutamatergic synapses that contribute to ethanol-associated dependence and neuronal injury.

Authors:  Mark A Prendergast; Patrick J Mulholland
Journal:  Addict Biol       Date:  2011-10-04       Impact factor: 4.280

Review 5.  Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse.

Authors:  George R Breese; Rajita Sinha; Markus Heilig
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

6.  Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice.

Authors:  Eric W Fish; Abigail E Agoglia; Michael C Krouse; R Grant Muller; J Elliott Robinson; C J Malanga
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

7.  Effects of concurrent access to multiple ethanol concentrations and repeated deprivations on alcohol intake of high-alcohol-drinking (HAD) rats.

Authors:  Zachary A Rodd; Richard L Bell; Kelly A Kuc; James M Murphy; Lawrence Lumeng; William J McBride
Journal:  Addict Biol       Date:  2008-12-12       Impact factor: 4.280

Review 8.  Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management.

Authors:  Matti Hillbom; Ilkka Pieninkeroinen; Maurizio Leone
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

9.  Electroencephalographic and behavioral correlates in rats during repeated ethanol withdrawal syndromes.

Authors:  F Poldrugo; O C Snead
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Dose- and time-dependent expression of anxiety-like behavior in the elevated plus-maze during withdrawal from acute and repeated intermittent ethanol intoxication in rats.

Authors:  Zhongqi Zhang; Andrew C Morse; George F Koob; Gery Schulteis
Journal:  Alcohol Clin Exp Res       Date:  2007-09-14       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.